Nafithromycin – India’s First Indigenous Antibiotic

On 20 November 2024, Union Minister Dr. Jitendra Singh launched India’s first indigenously developed antibiotic for resistant infections.

  • The antibiotic is named Nafithromycin.
  • It has been developed with support from the Biotechnology Industry Research Assistance Council (BIRAC).
  • BIRAC is a not-for-profit public sector enterprise under the Department of Biotechnology (DBT), Government of India.
  • The antibiotic has been commercialized by Wockhardt under the brand name “Miqnaf.”
  • It is specifically designed to combat Antimicrobial Resistance (AMR), a major global health challenge.
  • Nafithromycin is used for the treatment of Community-Acquired Bacterial Pneumonia (CABP).

GS Input

  • CABP is a serious infection caused by drug-resistant ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Buy May 2026 Issue

Already a Member? Login here

Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Be an Annual Subscriber

Related Content

Current Affairs